The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...

Pancreatic cancer, one of the most brutal and deadly diseases, sees approximately 10,800 new cases annually – 30 each day, in the UK – according to Cancer Research UK.It is the ...

How your back pain could be a sign of cancer - Abdominal pain or back pain could be symptoms of the UK’s fifth deadliest ...

An easy breath test could mean new hope in the early detection of pancreatic cancer, and medical experts say it could be the ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...

Lehigh Valley Health Network, part of Jefferson Health, dedicated the Peter and Odete Kelly Center for Personalized Cancer Immunotherapy in a celebratory event at Lehigh Valley Hospital–Cedar Crest. A ...

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax™, dramatically reduces multiple ...

A new study points to positive results for an immunotherapy treatment that could be used to treat pancreatic cancer.

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

From custom gene editing to a discovery that could help stop pancreatic cancer before it starts, these advances offer a ...